Not Yet RecruitingNot Applicable

Surgical Care And Recovery With Laser Evaluation Trial (SCARLET)

150 participantsStarted 2026-04-01

Plain-language summary

The Surgical Care and Recovery with Laser Evaluation Trial (S.C.A.R.L.E.T.) is a prospective, single-center clinical study conducted at AdventHealth Medical Group Plastic and Reconstructive Surgery at Innovation Tower. The study evaluates whether early adjuvant ProFractional laser and/or Broadband Light (BBL) therapy improves the appearance, texture, and patient-reported outcomes of surgical scars following major body-contouring procedures. Participants undergoing qualifying surgeries will be grouped as either cosmetic (receiving three laser/BBL sessions) or non-cosmetic (receiving standard care only). Scar outcomes will be assessed using validated instruments-SCAR-Q and Patient and Observer Scar Assessment Scale (POSAS)-along with standardized photographic analysis at serial follow-ups through six months postoperatively.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adults aged 18 years or older. Scheduled to undergo one or more of the following major body-contouring procedures during the study period: Brachioplasty (arm lift) Chest or breast contouring surgery Abdominoplasty or panniculectomy Buttock lift or lower body lift Thighplasty (thigh lift) Able and willing to provide written informed consent. Able to read and write in English (required for completion of validated questionnaires). Willing and able to comply with scheduled follow-up visits, questionnaires, and study procedures for up to 12 months post-surgery. Exclusion Criteria: Inability or unwillingness to provide informed consent. Inability to comply with study visits or procedures. Non-English speakers, as the validated SCAR-Q and POSAS instruments are not currently available in equivalent translations. Current use of nicotine or nicotine-containing products, including cigarettes, vaping, chewing tobacco, or nicotine replacement therapy, due to the known adverse effects of nicotine on wound healing and scar formation. Any medical condition, treatment, or circumstance that, in the opinion of the Investigator, may increase participant risk, compromise safety, or interfere with study participation or data integrity. Pregnant or breastfeeding women (laser/BBL therapy contraindicated in pregnancy). History of abnormal scar formation such as keloids or hypertrophic scarring (if deemed clinically significant by the investigator). Recent energy…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in SCAR-Q Total Score from Baseline to 6 Months Post-Surgery

Timeframe: Baseline (Preoperative) to 6 months post-surgery (±1 month)

Trial details

NCT IDNCT07359352

SponsorAdventHealth

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-04-01

Contact for this trial

Bridget Clinical Operations Manager, MS, MPH, CCRC, CCRP, PMP

407-303-5503 bridget.miller@adventhealth.com

View on ClinicalTrials.gov More Post-surgical Scars trials